Clinical trial

Curing Atrial Fibrillation in Heart Failure

NCT00292162 · NHS Greater Glasgow and Clyde, Other · Completed

Key facts

NCT number NCT00292162
Title Curing Atrial Fibrillation in Heart Failure
Official title Radiofrequency Ablation for Atrial Fibrillation in Advanced Chronic Heart Failure
Lead sponsor NHS Greater Glasgow and Clyde, Other
Status Completed
Study type Interventional
Conditions Chronic Heart Failure, Atrial Fibrillation
Intervention type Drug, Procedure
Interventions radiofrequency ablation, ACE inhibitor - ramipril, enalapril, captopril, perindopril, lisinopril, Beta Blocker (BB) - metoprolol, bisoprolol, carvedilol, Aldosterone Antagonists - spironolactone
Enrollment 41
Start date Jan 1, 2007
Primary completion Jul 1, 2009
Completion Jul 1, 2009
First posted Feb 15, 2006
Last update posted Jun 1, 2012
Countries United Kingdom

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies